This category includes all products that are using ex vivo or in vitro CRISPR-CAS or related methods to edit genomes or to regulate the expression of DNA sequences or the stability/translation of mRNA molecules. Base-editors are also included in this product group.

More information on legislation and regulations for research with genetically modified organisms (GMOs) can be found on the website of the Gene Therapy Office.